Quintiles teams with South Korean CRO; BASF sets deadline for Pronova deal;

> Quintiles is partnering with South Korea's BioCore, signing a two-year service deal to use the company's bioanalytical operations. More

> BASF says it will not re-extend its $823 million offer for Pronova beyond the Jan. 18 deadline; shareholders have until then to accept the deal. Article

> Pluristem is in the final stages of completing a new state-of-the-art manufacturing facility in Haifa, Israel. Release

> Icon ($ICLR) has elected former Amarin CEO Thomas Lynch to be its new chairman. News

> Private equity group American Capital is paying $200 million for Cambridge Major Laboratories, a Wisconsin API producer. Item

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.